Mounjaro KwikPen (Tirzepatide)
Save up to 54%
Available Options
2.5mg
1 pen (multi-dose, 4 weekly doses)
5mg
1 pen (multi-dose, 4 weekly doses)
7.5mg
1 pen (multi-dose, 4 weekly doses)
10mg
1 pen (multi-dose, 4 weekly doses)
12.5mg
1 pen (multi-dose, 4 weekly doses)
15mg
1 pen (multi-dose, 4 weekly doses)
Important Information
- • A valid prescription is required for all orders
- • Orders are shipped within 3–7 business days
- • Express shipping with cold chain packaging to keep your medication safe and effective
Description
Mounjaro KwikPen, containing tirzepatide, is a once-weekly injectable medication approved for adults with Type 2 diabetes. It is a groundbreaking dual incretin receptor agonist that acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual action helps regulate insulin secretion, reduce glucagon levels, slow down gastric emptying, and lead to better postprandial (after-meal) glucose control.
Mounjaro goes beyond traditional GLP-1 agonists like Ozempic by offering a synergistic effect from activating both hormone pathways. As a result, patients may experience superior improvements in HbA1c levels, better blood sugar stability, and clinically significant weight loss. Mounjaro is typically prescribed when diet, exercise, or other medications have not achieved desired glycemic control.
Fact Table
| Formula | C187H291N45O59 |
|---|---|
| License | EU EMA, US FDA |
| Chemical Name | Tirzepatide |
| Dosage (Strength) |
|
| Route | Subcutaneous injection |
| Bioavailability | ~80% |
Directions
- Inject Mounjaro once weekly on the same day, at any time, with or without food.
- Begin treatment with the lowest dose and increase gradually, following your healthcare provider’s guidance.
- Rotate injection sites (thigh, upper arm, or abdomen) to avoid skin irritation. Do not mix with insulin in the same injection.
Ingredients
The active ingredient is Tirzepatide. Each dose is delivered via a pre-filled pen for subcutaneous use only.
Cautions
- Do not use Mounjaro if you or a family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Avoid if allergic to tirzepatide or any excipients.
- Monitor for pancreatitis, gallbladder issues, diabetic retinopathy complications, or kidney function changes.
- Store pens in the refrigerator (36–46°F / 2–8°C) until first use. After first use, they may be stored at room temperature (up to 86°F / 30°C) for 21 days.
- Do not freeze.
Interactions
Mounjaro may delay gastric emptying and impact the absorption of oral medications such as birth control pills or antibiotics. Inform your healthcare provider about all prescription drugs, over-the-counter meds, and herbal supplements you are taking.
Side Effects
- Common: nausea, vomiting, diarrhea, constipation, reduced appetite, and abdominal discomfort.
- Rare but serious: pancreatitis, gallbladder disease, kidney impairment, and thyroid tumors. Discontinue use and contact your physician if severe reactions occur.
Frequently Asked Questions
What is Mounjaro KwikPen used for?
Mounjaro is prescribed for adults with Type 2 diabetes to help lower blood sugar and support weight loss when used alongside diet and exercise.
How does Mounjaro help with blood sugar control?
Mounjaro activates GIP and GLP-1 receptors, increasing insulin production, reducing liver glucose output, and slowing digestion.
Is Mounjaro effective for weight loss?
Yes, in clinical trials, Mounjaro led to weight loss of up to 22.5 lbs (10.2 kg), especially in patients on higher doses.
What makes Mounjaro different from Ozempic?
Unlike Ozempic, which targets only GLP-1, Mounjaro targets both GIP and GLP-1, offering more comprehensive metabolic control.
How fast does Mounjaro start working?
Patients typically begin seeing improvements in blood sugar levels within the first few weeks, with full benefits in 12–16 weeks.
What are the common side effects of Mounjaro?
Most common are mild gastrointestinal issues: nausea, vomiting, diarrhea, and appetite loss. These tend to improve over time.
Can Mounjaro be used with insulin or metformin?
Yes, but your doctor will adjust dosages to avoid hypoglycemia. It’s often combined with metformin or SGLT2 inhibitors.
Is Mounjaro FDA-approved for weight loss?
As of now, Mounjaro is approved for Type 2 diabetes, but weight loss is a well-documented benefit. A separate approval for obesity treatment is under review.
Is Mounjaro available internationally?
Yes, Mounjaro has regulatory approval in the US, EU, Canada, and several other countries worldwide.
Do I need to refrigerate Mounjaro?
Yes, before first use. After opening, it can be kept at room temperature for 21 days but should be kept out of direct heat or sunlight.
Important Note
The information above is provided for educational purposes only and should not replace professional medical advice. Please consult a qualified healthcare provider for personalized guidance on medication safety, suitability, and proper use.